REFERENCES
1. J. Larry Jameson, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci,
Stephen L. Hauser JL, ed. Disorders of Immune-Mediated Injury. In:Harrison’s Principles of Internal Medicine . 20th Editi. New
York : McGraw-Hill Education; 2018:2600-2607.
2. Yahalom M, Koren O, Turgeman Y. High Degree Atrioventricular Block
Complicated Cardiac Sarcoidosis : Case Report. 2018:157-163.
doi:10.4236/wjcs.2018.89015
3. Nunes H, Freynet O, Naggara N, et al. Cardiac Sarcoidosis.Semin Respir Crit Care Med . 2010;31(04):428-441.
doi:10.1055/s-0030-1262211
4. Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R.
Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn
Ther . 2016;6(1):50-63. doi:10.3978/j.issn.2223-3652.2015.12.13
5. Jotterand M, Grabherr S, Lobrinus JA, Michaud K. Sudden cardiac death
and sarcoidosis of the heart in a young patient. Cardiovasc
Pathol . 2017;28:18-20. doi:10.1016/j.carpath.2017.01.003
6. Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac
sarcoidosis. J Intern Med . 2011;270(5):461-468.
doi:10.1111/j.1365-2796.2011.02396.x
7. Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, George P. Review paper
Cardiac sarcoidosis : a comprehensive review. 2011.
doi:10.5114/aoms.2011.24118
8. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: A
morphologic study of 38 autopsies with clinicopathologic correlations.Arch Pathol Lab Med . 1995;119(2):167-172.
9. Judson MA. The diagnosis of sarcoidosis. Curr Opin Pulm Med .
2019;25(5):484-496. doi:10.1097/MCP.0000000000000596
10. Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac Sarcoidosis.
2016;68(4). doi:10.1016/j.jacc.2016.03.605
11. Judson MA. Screening sarcoidosis patients for cardiac sarcoidosis:
What the data really show. Respir Med . 2019;154:155-157.
doi:10.1016/j.rmed.2019.05.007
12. Tan JL, Fong HK, Birati EY, Han Y. Cardiac Sarcoidosis. Am J
Cardiol . 2019;123(3):513-522. doi:10.1016/j.amjcard.2018.10.021
13. Evanchan JP, Crouser ED. Cardiac Sarcoidosis : Recent Advances in
Diagnosis and Treatment and an Argument for the Need for a Systematic
Multidisciplinary Approach to Management. 2013;4(March):1160-1174.
doi:10.19102/icrm.2013.040308
14. Selan JC, Michaelson M, Fanburg BL, Estes NAM. Evaluation and
management of heart rhythm disturbances due to cardiac sarcoidosis.Hear Lung Circ . 2014;23(12):1100-1109.
doi:10.1016/j.hlc.2014.07.065
15. Orii M, Tanimoto T, Ota S, et al. Diagnostic accuracy of cardiac
magnetic resonance imaging for cardiac sarcoidosis in complete heart
block patients implanted with magnetic resonance-conditional pacemaker.J Cardiol . 2020;(2019). doi:10.1016/j.jjcc.2020.02.014
16. Kouranos V, Tzelepis GE, Rapti A, et al. Complementary Role of CMR
to Conventional Screening in the Diagnosis and Prognosis of Cardiac
Sarcoidosis. JACC Cardiovasc Imaging . 2017;10(12):1437-1447.
doi:10.1016/j.jcmg.2016.11.019
17. Stanton KM, Ganigara M, Corte P, et al. The Utility of Cardiac
Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis.Hear Lung Circ . 2017;26(11):1191-1199.
doi:10.1016/j.hlc.2017.02.021
18. Hamzeh N, Steckman DA, Sauer WH, Judson MA. Pathophysiology and
clinical management of cardiac sarcoidosis. Nat Rev Cardiol .
2015;12(5):278-288. doi:10.1038/nrcardio.2015.22
19. Birnie DH, Kandolin R, Nery PB, Kupari M. Cardiac manifestations of
sarcoidosis: Diagnosis and management. Eur Heart J .
2017;38(35):2663-2670. doi:10.1093/eurheartj/ehw328
20. Kopriva P, Griva M, Tüdös Z. Management of cardiac sarcoidosis – A
practical guide. Cor Vasa . 2018;60(2):e155-e164.
doi:10.1016/j.crvasa.2017.05.012
21. Ballul T, Borie R, Crestani B, et al. Treatment of cardiac
sarcoidosis: A comparative study of steroids and steroids plus
immunosuppressive drugs. Int J Cardiol . 2019;276:208-211.
doi:10.1016/j.ijcard.2018.11.131
22. Ashraf S, Briasoulis A, Afonso L. Infrequent cardiac manifestations
of sarcoidosis. Hear Lung J Acute Crit Care . 2016;45(6):515-516.
doi:10.1016/j.hrtlng.2016.08.013
23. Kandolin R, Lehtonen J, Kupari M. Cardiac Sarcoidosis and Giant Cell
Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged
Adults. Circ Arrhythmia Electrophysiol . 2011;4(3):303-309.
doi:10.1161/CIRCEP.110.959254
24. Birnie DH, Sauer WH, Bogun F, et al. HRS Expert Consensus Statement
on the Diagnosis and Management of Arrhythmias Associated With Cardiac
Sarcoidosis. doi:10.1016/j.hrthm.2014.03.043
25. Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the
initial manifestation of cardiac sarcoidosis in middle-aged adults.J Cardiovasc Electrophysiol . 2014;25(8):875-881.
doi:10.1111/jce.12401
26. Salama A, Abdullah AS, Nadkarni N, Alweis R. SARCOIDOSIS INCREASES
THE RISK OF COMPLETE HEART BLOCK: A REVIEW FROM THE NATIONAL INPATIENT
SAMPLE. J Am Coll Cardiol . 2019;73(9):543.
doi:10.1016/s0735-1097(19)31151-9
27. Nordenswan H-K, Lehtonen J, Ekström K, et al. Outcome of Cardiac
Sarcoidosis Presenting With High-Grade Atrioventricular Block.Circ Arrhythm Electrophysiol . 2018;11(8):e006145.
doi:10.1161/CIRCEP.117.006145
28. Ghanizada M, Rossing K, Bundgaard H, Gustafsson F. DA N I S H M E D
I C A L J O U R N A L. Dan Med J . 2018;65(4):A5462.
29. SCHULLER JL, OLSON MD, ZIPSE MM, et al. Electrocardiographic
Characteristics in Patients With Pulmonary Sarcoidosis Indicating
Cardiac Involvement. J Cardiovasc Electrophysiol .
2011;22(11):1243-1248. doi:10.1111/j.1540-8167.2011.02099.x
30. Gheysens O, Cleemput J Van, Wuyts W. Natural evolution of cardiac
sarcoidosis in an asymptomatic patient : a case report. 2019:1-6.
doi:10.1093/ehjcr/ytz099
31. Segura AM, Radovancevic R, Demirozu ZT, Frazier OH, Buja LM.
Granulomatous myocarditis in severe heart failure patients undergoing
implantation of a left ventricular assist device. Cardiovasc
Pathol . 2014;23(1):17-20. doi:10.1016/j.carpath.2013.06.005
32. Roberts WC, Roberts CC, Ko JM, Filardo G, Capehart JE, Hall SA.
Morphologic features of the recipient heart in patients having cardiac
transplantation and analysis of the congruence or incongruence between
the clinical and morphologic diagnoses. Med (United States) .
2014;93(5):211-235. doi:10.1097/MD.0000000000000038
33. Statement on Sarcoidosis. Am J Respir Crit Care Med .
1999;160(2):736-755. doi:10.1164/ajrccm.160.2.ats4-99
34. Chapelon-Abric C, Sene D, Saadoun D, et al. Cardiac sarcoidosis:
Diagnosis, therapeutic management and prognostic factors. Arch
Cardiovasc Dis . 2017;110(8-9):456-465. doi:10.1016/j.acvd.2016.12.014
35. Osborne MT, Hulten EA, Singh A, et al. Reduction in
18F-fluorodeoxyglucose uptake on serial cardiac positron emission
tomography is associated with improved left ventricular ejection
fraction in patients with cardiac sarcoidosis. J Nucl Cardiol .
2014;21(1):166-174. doi:10.1007/s12350-013-9828-6
36. Hamzeh N, Steckman DA, Sauer WH, Judson MA. Pathophysiology and
clinical management of cardiac sarcoidosis. Nat Rev Cardiol .
2015;12(5):278-288. doi:10.1038/nrcardio.2015.22